Sean Duffy Sells 12,942 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 12,942 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $24.81, for a total value of $321,091.02. Following the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $10,218,271.41. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Omada Health Price Performance

Shares of NASDAQ:OMDA traded down $0.98 during midday trading on Tuesday, reaching $24.01. The company had a trading volume of 1,906,414 shares, compared to its average volume of 1,272,868. The stock has a market capitalization of $1.43 billion, a P/E ratio of 480.20 and a beta of 1.73. The stock’s fifty day moving average price is $20.49 and its 200-day moving average price is $16.26. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.67%. As a group, sell-side analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research note on Friday, May 8th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a report on Monday, July 20th. Barclays lifted their target price on Omada Health from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Canaccord Genuity Group boosted their price target on Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Finally, Citizens Jmp upped their price target on Omada Health from $21.00 to $27.00 and gave the company a “market outperform” rating in a research report on Monday, July 20th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.67.

Institutional Investors Weigh In On Omada Health

Institutional investors and hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. acquired a new position in Omada Health in the second quarter valued at approximately $32,000. Quarry LP acquired a new stake in shares of Omada Health during the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health in the 4th quarter worth approximately $32,000. Inlight Wealth Management LLC acquired a new position in Omada Health during the 4th quarter valued at approximately $45,000. Finally, Versant Capital Management Inc boosted its position in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the period.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.